| Dr Neil Raj Batta, MD | |
|
1519 3rd St Se Ste 101, Puyallup, WA 98372-3742 | |
| (253) 841-0705 | |
| (253) 841-4527 |
| Full Name | Dr Neil Raj Batta |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 8 Years |
| Location | 1519 3rd St Se Ste 101, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841653540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | MD61159582 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| St Anthony Hospital | Gig harbor, WA | Hospital |
| Harrison Medical Center | Bremerton, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Sound Neurosurgery Pllc | 1254225899 | 15 |
News Archive
New York Times' The Caucus blog: "Conceding his health care overhaul had 'run into a bit of a buzz saw,' President Obama vowed on Friday to keep fighting for legislation that will 'hold the insurance industry accountable and bring more stability and security to folks in our health care system'" (Stolberg, 1/22).
Improperly formed proteins can cause a host of serious illnesses, from muscular dystrophy to cystic fibrosis. A question of enormous import in research, beyond the challenge of determining how malformed proteins contribute to specific disease processes, is figuring out ways to prevent or reduce the pathologies they cause.
Two-thirds of developing countries are on track or close to reaching the U.N. Millennium Development Goal targets to reduce extreme poverty and hunger, according to a World Bank-IMF report released Friday to coincide with a meeting of the groups in Washington, D.C., over the weekend, Agence France-Presse/Edmonton Journal reports.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 3 days ago
| Entity Name | South Sound Neurosurgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417992389 PECOS PAC ID: 1254225899 Enrollment ID: O20040320000586 |
News Archive
New York Times' The Caucus blog: "Conceding his health care overhaul had 'run into a bit of a buzz saw,' President Obama vowed on Friday to keep fighting for legislation that will 'hold the insurance industry accountable and bring more stability and security to folks in our health care system'" (Stolberg, 1/22).
Improperly formed proteins can cause a host of serious illnesses, from muscular dystrophy to cystic fibrosis. A question of enormous import in research, beyond the challenge of determining how malformed proteins contribute to specific disease processes, is figuring out ways to prevent or reduce the pathologies they cause.
Two-thirds of developing countries are on track or close to reaching the U.N. Millennium Development Goal targets to reduce extreme poverty and hunger, according to a World Bank-IMF report released Friday to coincide with a meeting of the groups in Washington, D.C., over the weekend, Agence France-Presse/Edmonton Journal reports.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neil Raj Batta, MD 4700 Point Fosdick Dr Ste 205, Gig Harbor, WA 98335-1706 Ph: (253) 841-0842 | Dr Neil Raj Batta, MD 1519 3rd St Se Ste 101, Puyallup, WA 98372-3742 Ph: (253) 841-0705 |
News Archive
New York Times' The Caucus blog: "Conceding his health care overhaul had 'run into a bit of a buzz saw,' President Obama vowed on Friday to keep fighting for legislation that will 'hold the insurance industry accountable and bring more stability and security to folks in our health care system'" (Stolberg, 1/22).
Improperly formed proteins can cause a host of serious illnesses, from muscular dystrophy to cystic fibrosis. A question of enormous import in research, beyond the challenge of determining how malformed proteins contribute to specific disease processes, is figuring out ways to prevent or reduce the pathologies they cause.
Two-thirds of developing countries are on track or close to reaching the U.N. Millennium Development Goal targets to reduce extreme poverty and hunger, according to a World Bank-IMF report released Friday to coincide with a meeting of the groups in Washington, D.C., over the weekend, Agence France-Presse/Edmonton Journal reports.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
› Verified 3 days ago
Sophie Warshaw, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8011 112th Street Ct E, Puyallup, WA 98373 Phone: 253-848-0662 Fax: 253-848-8567 | |
Lavina Jethani, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-3265 Fax: 931-208-3645 | |
Keith M. D'souza, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-7900 | |
Terese Brunoff, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1503 W Stewart, Puyallup, WA 98371 Phone: 253-848-6847 | |
Paul B Nutter, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-2700 | |
Jeffery Thomas Berdan, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se Ste 4200, Puyallup, WA 98372 Phone: 253-459-7000 | |
John E Benson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 407 14th Ave Se, Puyallup, WA 98372 Phone: 253-697-1664 |